References
- Abou-Khalil, B., & Schmidt, d. (2012). Antiepileptic drugs. Advantages and disadvantages. In Handbook of clinical neurology (Vol. 108, pp. 723–739). Elsevier.
- Baig, M. H., Ahmad, K., Roy, S., Ashraf, J. M., Adil, M., Siddiqui, M. H., Khan, S., Kamal, M. A., Provazník, I., & Choi, I. (2016). Computer aided drug design: Success and limitations. Current Pharmaceutical Design, 22(5), 572–581. https://doi.org/https://doi.org/10.2174/1381612822666151125000550
- Becker, H. M., Klier, M., & Deitmer, J. W. (2014). Carbonic anhydrase: Mechanism, regulation, links to disease, and industrial applications. Subcellular Biochemistry, 75, 105–134. https://doi.org/https://doi.org/10.1007/978-94-007-7359-2
- Bertrand, H., & Triballeau, N. (2005). Virtual screening workflow development guided by the ROC Curve approach. application to high-throughput docking on metabotropic glutamate receptor subtype 4. Journal of Medicinal Chemistry, 48(7), 2534-2547. https://doi.org/https://doi.org/10.1021/jm049092j
- Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., … Shaw, D. E. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In ACM/IEEE SC 2006 Conference (SC’06). https://doi.org/https://doi.org/10.1109/SC.2006.54
- Bruno, E., Buemi, M. R., De Luca, L., Ferro, S., Monforte, A.-M., Supuran, C. T., Vullo, D., De Sarro, G., Russo, E., & Gitto, R. (2016). In vivo evaluation of selective carbonic anhydrase inhibitors as potential anticonvulsant agents. ChemMedChem, 11(16), 1812–1818. https://doi.org/https://doi.org/10.1002/cmdc.201500596
- Buemi, M. R., Di Fiore, A., De Luca, L., Angeli, A., Mancuso, F., Ferro, S., Monti, S. M., Buonanno, M., Russo, E., De Sarro, G. & De Simone, G. (2019). Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety. European Journal of Medicinal Chemistry, 163, 443–452. https://doi.org/https://doi.org/10.1016/j.ejmech.2018.11.073
- Dixon, S. L., Duan, J., Smith, E., Von Bargen, C. D., Sherman, W., & Repasky, M. P. (2016). AutoQSAR: An automated machine learning tool for best-practice quantitative structure-activity relationship modeling. Future Medicinal Chemistry, 8(15), 1825–1839. https://doi.org/https://doi.org/10.4155/fmc-2016-0093
- Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10-11), 647–671. https://doi.org/https://doi.org/10.1007/s10822-006-9087-6
- Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006). PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology and Drug Design, 67(5), 370-372. https://doi.org/https://doi.org/10.1111/j.1747-0285.2006.00384.x
- El-Azab, A. S., Abdel-Aziz, A. A. M., Ayyad, R. R., Ceruso, M., & Supuran, C. T. (2016). Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds. Bioorganic & Medicinal Chemistry, 24(1), 20–25. https://doi.org/https://doi.org/10.1016/j.bmc.2015.11.034
- Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., & Mee, R. P. (1997). Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design, 11(5), 425–445. https://doi.org/https://doi.org/10.1023/A:1007996124545
- Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/https://doi.org/10.1021/jm0306430
- Hanaya, R., & Arita, K. (2016). The new antiepileptic drugs: Their neuropharmacology and clinical indications. Neurologia Medico-Chirurgica, 56(5), 205-220. https://doi.org/https://doi.org/10.2176/nmc.ra.2015-0344
- Kalinin, S., Kopylov, S., Tuccinardi, T., Sapegin, A., Dar'in, D., Angeli, A., Supuran, C. T., & Krasavin, M. (2017). Lucky Switcheroo: Dramatic potency and selectivity improvement of imidazoline inhibitors of human carbonic anhydrase VII. ACS Medicinal Chemistry Letters, 8(10), 1105–1109. https://doi.org/https://doi.org/10.1021/acsmedchemlett.7b00300
- Kirchmair, J., Markt, P., Distinto, S., Wolber, G., & Langer, T. (2008). Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection - What can we learn from earlier mistakes? Journal of Computer-Aided Molecular Design, 22, 213–228. https://doi.org/https://doi.org/10.1007/s10822-007-9163-6
- Kumar, A., Rai, S., Rathi, E., Agarwal, P., & Kini, S. G. (2020). Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: Extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1726816
- Kumar, A., Rathi, E., & Kini, S. G. (2020a). Drug repurposing approach for the identification and designing of potential E6 inhibitors against cervical cancer: An in silico investigation. Structural Chemistry, 31(1), 141–153. https://doi.org/https://doi.org/10.1007/s11224-019-01378-x
- Kumar, A., Rathi, E., & Kini, S. G. (2020b). Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: Atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies. Journal of Biomolecular Structure & Dynamics, 38(7), 2156–2170. https://doi.org/https://doi.org/10.1080/07391102.2019.1626285
- Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157. https://doi.org/https://doi.org/10.2174/157340911795677602
- Mishra, C. B., Tiwari, M., & Supuran, C. T. (2020). Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Medicinal Research Reviews, 40(6), 2485–2565. https://doi.org/https://doi.org/10.1002/med.21713
- Mishra, C. B., Kumari, S., Angeli, A., Bua, S., Tiwari, M., & Supuran, C. T. (2018). Discovery of benzenesulfonamide derivatives as carbonic anhydrase inhibitors with effective anticonvulsant action: Design, synthesis, and pharmacological evaluation. Journal of Medicinal Chemistry, 61(7), 3151–3165. https://doi.org/https://doi.org/10.1021/acs.jmedchem.8b00208
- Pilipuitytė, V., & Matulis, D. (2015). Intrinsic thermodynamics of trifluoromethanesulfonamide and ethoxzolamide binding to human carbonic anhydrase VII. Journal of Molecular Recognition, 28(3), 166–172. https://doi.org/https://doi.org/10.1002/jmr.2404
- Ramachandran, R., & Piramanyagam, S. (2017). Pharmacophore modeling, atom based 3D-QSAR and Molecular docking approaches to screen C-X-C chemokine receptor type 4 antagonists as microbicides for human immunodeficiency virus-1. Virusdisease, 28(3), 272–280. https://doi.org/https://doi.org/10.1007/s13337-017-0397-1
- Stefanucci, A., Angeli, A., Dimmito, M. P., Luisi, G., Del Prete, S., Capasso, C., Donald, W. A., Mollica, A., & Supuran, C. T. (2018). Activation of β- and γ-carbonic anhydrases from pathogenic bacteria with tripeptides. Journal of Enzyme Inhibition and Medicinal Chemistry, 33(1), 945–950. https://doi.org/https://doi.org/10.1080/14756366.2018.1468530
- Supuran, C. T. (2008). Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Reviews. Drug Discovery, 7(2), 168–181. https://doi.org/https://doi.org/10.1038/nrd2467
- Supuran, C. T. (2016). How many carbonic anhydrase inhibition mechanisms exist? Journal of Enzyme Inhibition and Medicinal Chemistry, 31(3), 345–360. https://doi.org/https://doi.org/10.3109/14756366.2015.1122001
- Supuran, C. T. (2018). Carbonic anhydrases and metabolism. Metabolites, 8(2), 25. https://doi.org/https://doi.org/10.3390/metabo8020025
- Usha, T., Shanmugarajan, D., Goyal, A. K., Kumar, C. S., & Middha, S. K. (2017). Recent updates on computer-aided drug discovery: Time for a paradigm shift. Current Topics in Medicinal Chemistry, 17(30), 3296–3307. https://doi.org/https://doi.org/10.2174/1568026618666180101163651
- Xiong, Z. Q., Saggau, P., & Stringer, J. L. (2000). Activity-dependent intracellular acidification correlates with the duration of seizure activity. Journal of Neuroscience, 20(4), 1290–1296. https://doi.org/https://doi.org/10.1523/JNEUROSCI.20-04-01290.2000
- Yang, S., Lu, D., & Ouyang, P. (2018). Design, synthesis and evaluation of novel N-phenylbutanamide derivatives as KCNQ openers for the treatment of epilepsy. Bioorganic & Medicinal Chemistry Letters, 28(17), 3004–3008. https://doi.org/https://doi.org/10.1016/j.bmcl.2018.05.019
- Zimmerman, S., Ferry, J., & Supuran, C. (2007). Inhibition of the Archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases. Current Topics in Medicinal Chemistry, 7(9), 901–908. https://doi.org/https://doi.org/10.2174/156802607780636753